A detailed history of Aqr Capital Management LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 12,380 shares of CTLT stock, worth $754,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,380
Previous 10,675 15.97%
Holding current value
$754,932
Previous $600,000 24.83%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.16 - $60.96 $95,752 - $103,936
1,705 Added 15.97%
12,380 $749,000
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $40,185 - $42,765
750 Added 7.56%
10,675 $600,000
Q1 2024

May 15, 2024

BUY
$42.56 - $59.82 $422,408 - $593,713
9,925 New
9,925 $560,000
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $2.76 Million - $5.39 Million
66,604 Added 615.79%
77,420 $3.48 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $72 - $113
1 Added 0.01%
10,816 $783,000
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $315,053 - $412,062
-3,613 Reduced 25.04%
10,815 $1.14 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $12,336 - $16,085
-113 Reduced 0.78%
14,428 $1.92 Million
Q2 2021

Aug 16, 2021

SELL
$100.34 - $115.69 $443,201 - $511,002
-4,417 Reduced 23.3%
14,541 $1.57 Million
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $167,694 - $206,946
-1,652 Reduced 8.02%
18,958 $1.99 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $378,129 - $463,900
4,403 Added 27.17%
20,610 $2.12 Million
Q3 2020

Nov 16, 2020

SELL
$72.74 - $92.5 $5,310 - $6,752
-73 Reduced 0.45%
16,207 $1.38 Million
Q2 2020

Aug 17, 2020

BUY
$48.02 - $79.04 $521,497 - $858,374
10,860 Added 200.37%
16,280 $1.17 Million
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $200,269 - $341,189
5,420 New
5,420 $282,000
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $2.46 Million - $3.8 Million
-82,106 Closed
0 $0
Q3 2018

Nov 15, 2018

BUY
$40.12 - $45.55 $2.31 Million - $2.62 Million
57,562 Added 234.53%
82,106 $3.74 Million
Q2 2018

Aug 14, 2018

SELL
$38.72 - $42.52 $10.3 Million - $11.3 Million
-266,694 Reduced 91.57%
24,544 $1.03 Million
Q1 2018

May 15, 2018

SELL
$39.4 - $47.39 $7.24 Million - $8.71 Million
-183,703 Reduced 38.68%
291,238 $12 Million
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $13 Million - $15 Million
348,901 Added 276.82%
474,941 $19.5 Million
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $4.25 Million - $5.25 Million
126,040
126,040 $5.03 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.